Oct 29, 2026 | 5 minute read
Earlier this year, the World Health Assembly adopted its first comprehensive resolution on stroke [1]. The resolution aims to reduce the burden of stroke globally, covering prevention, acute care, rehabilitation and health-system readiness [2].

As a clinician and the Chief Medical Officer at Philips, I welcomed this decision. Stroke remains a major global health challenge. It is the world’s second-leading cause of death worldwide and the third-leading cause of disability [3].
The WHO resolution is significant because it recognizes that reducing the devastating impact of stroke requires coordinated action across the entire care pathway.
However, as we mark the first World Stroke Day since this landmark resolution, the key question is whether this commitment will ultimately improve stroke care for people around the world.
Stroke is distinctive among noncommunicable diseases, as many stroke cases can be prevented, and timely treatment and rehabilitation can improve outcomes.
Many strokes are linked to risk factors, such as high blood pressure, that can be identified and managed, while treatments like intravenous thrombolysis and mechanical thrombectomy can reduce the risk of death or disability when delivered in time [2].
And yet, despite these advances, most people with stroke cannot access the care they need. The median global access rate for thrombectomy is below 3%, while approximately 87% of stroke deaths occur in low- and middle-income countries (LMICs) [2,3].
This is especially worrying when considering that almost 94 million people are living with the effects of stroke today, and that one in four survivors will have another stroke within five years [4].
The evidence is clear, but what’s missing is the system around it, which is the gap the WHO resolution aims to close [2].
A global resolution sets the agenda, but national action is what delivers on its promise.
That is why countries must adopt the global commitment into their national plans. The resolution urges WHO Member States to include stroke in their national cardiovascular disease plans, neurological disorder strategies and universal health coverage planning, with dedicated objectives across prevention, acute care and rehabilitation. Where appropriate, a dedicated national stroke plan can do the same job.
A good plan translates the global commitment into local priorities. It names who is responsible, directs investment and gives governments and healthcare authorities a means to track progress.
Without a clear and effective national plan, even the strongest resolution risks staying on paper.
"Action" can sound abstract, so it helps to be specific about what it means at each stage of care:

The WHO resolution is clear about what makes implementation work: trained health workers, affordable access to medicines and services, sustainable financing, data to guide decisions, and attention to underserved populations [2].
I encourage every policymaker to turn these into three simple questions:
If a national plan can answer those questions, it is ready to deliver. If it cannot, it is not yet an effective plan.
The estimated direct and indirect costs of stroke globally are over USD 891 billion annually [3]. Investing in prevention and treatment may improve health outcomes and reduce the impact on health systems.
The impact of stroke is growing, and people in low- and middle-income countries (LMICs) are disproportionately affected. Access to prevention, treatment and rehabilitation vary widely [3].
So, national plans should not assume every country starts from the same place. They need to reflect local needs and reduce geographic and financial barriers. For some countries, the priority will be improving blood pressure control in primary care settings. For others, it will be building stroke units or extending access to thrombectomy beyond major cities.
Where someone lives should not decide whether they have a fair chance at recovery, and national plans must have this principle at their core.
Timely care matters in stroke. Diagnostic imaging, image-guided therapy, and connected data can support care teams in making informed decisions and reducing delays.
However, technology only delivers as part of a connected ecosystem. Imaging and interventional systems are most useful when teams have the training, pathways, infrastructure, and resources to use them, so people can access the care.
That is also why workforce training matters as much as equipment. Building skills, from emergency teams to interventional specialists, is what turns capability into access.

The WHO resolution gives countries a framework, but implementing it will take leadership and collaboration among governments, healthcare professionals, stroke survivors, civil society and the private sector. No single organization can do this alone.
Philips is committed to doing our part. As a founding member of the Global Stroke Action Coalition, and through our work with the World Stroke Organization and other partners, we will keep supporting countries as they move from commitment to delivery. This includes sharing evidence, helping build the case for investment, and working alongside health systems on the pathways, skills and technologies that make timely stroke care possible.
We measure success by whether more people can access the right care at the right time to prevent, treat or recover from stroke.
To help achieve this, in honour of World Stroke Day, I call on governments to put stroke into their national health plans. Stroke is a challenge we can address together. Let’s turn commitment into action so more people can access timely care.
Sources [1] World Health Organization. Seventy-ninth World Health Assembly – Daily update: 22 May 2026. Available at: https://www.who.int/news/item/22-05-2026-seventy-ninth-world-health-assembly-daily-update-22-may-2026. Last accessed: October 2026.
[2] World Health Organization. Reducing the burden of stroke: strengthening prevention, acute care, rehabilitation and health-system readiness. 3 February 2026. Available at: https://apps.who.int/gb/ebwha/pdf_files/EB158/B158_R4-en.pdf. Last accessed: October 2026.
[3] Feigin V, Owolabi M, Feigin V et al. Pragmatic solutions to reduce the global burden of stroke: a World Stroke Organization–Lancet Neurology Commission. The Lancet Neurology, 2023; 22, 1160-1206.>
[4] Feigin V, Abate M, Abate Y et al. Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Neurology, 23, 973-1003.